Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Kat. Nr. | Arten | Produktbeschreibung | Struktur | Reinheit | Merkmal |
---|---|---|---|---|---|
CHEK-ATP122 | Human | HEK293/Human ENPP3 Stable Cell Line | |||
EN3-M5263 | Mouse | Mouse ENPP3 Protein, Fc Tag (active enzyme, MALS verified) |
|
||
EN3-H5267 | Human | Human ENPP3 / CD203c Protein, Fc Tag (active enzyme, MALS verified) |
|
||
EN3-H82E5 | Human | Biotinylated ENPP3 protein, Avitag™,His Tag (active enzyme) |
|
||
EN3-M52H3 | Mouse | Mouse ENPP3 / CD203c Protein, His Tag (active enzyme, MALS verified) |
|
||
EN3-H52H4 | Human | Human ENPP3 / CD203c Protein, His Tag (active enzyme) |
|
Expression analysis of human ENPP3 on HEK293/Human ENPP3 Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human ENPP3 Stable Cell Line or negative control cell using PE-labeled anti-human ENPP3 antibody.
The purity of Mouse ENPP3 Protein, Fc Tag (Cat. No. EN3-M5263) is more than 90% and the molecular weight of this protein is around 245-285 kDa verified by SEC-MALS.
The purity of Human ENPP3 Protein, Fc Tag (Cat. No. EN3-H5267) is more than 90% and the molecular weight of this protein is around 265-315 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
AGS-16C3F | AGS-16F; AGS-16C3F; AGS-16M8F | Phase 2 Clinical | Agensys Inc | Carcinoma, Renal Cell | Details |
XmAb-819 | XmAb-819 | Phase 1 Clinical | Xencor Inc | Kidney Neoplasms; Carcinoma, Renal Cell | Details |
JNJ-87890387 | JNJ-87890387 | Phase 1 Clinical | Janssen Research & Development Llc | Solid tumours | Details |
AGS-16C3F | AGS-16F; AGS-16C3F; AGS-16M8F | Phase 2 Clinical | Agensys Inc | Carcinoma, Renal Cell | Details |
XmAb-819 | XmAb-819 | Phase 1 Clinical | Xencor Inc | Kidney Neoplasms; Carcinoma, Renal Cell | Details |
JNJ-87890387 | JNJ-87890387 | Phase 1 Clinical | Janssen Research & Development Llc | Solid tumours | Details |
This web search service is supported by Google Inc.